| Product Code: ETC6146146 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Argentina prostacyclin market, the import trend exhibited a growth rate of 15.58% from 2023 to 2024, contrasting with a compound annual growth rate (CAGR) of -9.64% for the period 2020-2024. This significant positive momentum in import growth from 2023-2024 may be attributed to a notable demand shift or a recovery in market conditions during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Prostacyclin Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Prostacyclin Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Prostacyclin Market - Industry Life Cycle |
3.4 Argentina Prostacyclin Market - Porter's Five Forces |
3.5 Argentina Prostacyclin Market Revenues & Volume Share, By Diseases, 2021 & 2031F |
3.6 Argentina Prostacyclin Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Argentina Prostacyclin Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Argentina Prostacyclin Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Argentina Prostacyclin Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Argentina Prostacyclin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Argentina Prostacyclin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as pulmonary arterial hypertension (PAH) in Argentina |
4.2.2 Growing awareness about the benefits of prostacyclin therapy in managing PAH |
4.2.3 Favorable government policies supporting the development and adoption of advanced medical treatments |
4.3 Market Restraints |
4.3.1 High cost associated with prostacyclin therapy limiting affordability for a significant portion of the population |
4.3.2 Limited availability of specialized healthcare facilities for the diagnosis and treatment of PAH in certain regions of Argentina |
5 Argentina Prostacyclin Market Trends |
6 Argentina Prostacyclin Market, By Types |
6.1 Argentina Prostacyclin Market, By Diseases |
6.1.1 Overview and Analysis |
6.1.2 Argentina Prostacyclin Market Revenues & Volume, By Diseases, 2021- 2031F |
6.1.3 Argentina Prostacyclin Market Revenues & Volume, By Pulmonary Arterial Hypertension, 2021- 2031F |
6.1.4 Argentina Prostacyclin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Argentina Prostacyclin Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Argentina Prostacyclin Market Revenues & Volume, By Epoprostenol, 2021- 2031F |
6.2.3 Argentina Prostacyclin Market Revenues & Volume, By Treprostinil, 2021- 2031F |
6.2.4 Argentina Prostacyclin Market Revenues & Volume, By Iloprost, 2021- 2031F |
6.3 Argentina Prostacyclin Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Argentina Prostacyclin Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 Argentina Prostacyclin Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 Argentina Prostacyclin Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Argentina Prostacyclin Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Argentina Prostacyclin Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Argentina Prostacyclin Market Revenues & Volume, By Inhalations, 2021- 2031F |
6.5 Argentina Prostacyclin Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Argentina Prostacyclin Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Argentina Prostacyclin Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Argentina Prostacyclin Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6 Argentina Prostacyclin Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Argentina Prostacyclin Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.6.3 Argentina Prostacyclin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.4 Argentina Prostacyclin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.5 Argentina Prostacyclin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Argentina Prostacyclin Market Import-Export Trade Statistics |
7.1 Argentina Prostacyclin Market Export to Major Countries |
7.2 Argentina Prostacyclin Market Imports from Major Countries |
8 Argentina Prostacyclin Market Key Performance Indicators |
8.1 Patient adherence rate to prostacyclin therapy |
8.2 Number of healthcare professionals trained in PAH diagnosis and prostacyclin therapy |
8.3 Rate of new product development and approvals in the prostacyclin market in Argentina |
9 Argentina Prostacyclin Market - Opportunity Assessment |
9.1 Argentina Prostacyclin Market Opportunity Assessment, By Diseases, 2021 & 2031F |
9.2 Argentina Prostacyclin Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Argentina Prostacyclin Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Argentina Prostacyclin Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Argentina Prostacyclin Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Argentina Prostacyclin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Prostacyclin Market - Competitive Landscape |
10.1 Argentina Prostacyclin Market Revenue Share, By Companies, 2024 |
10.2 Argentina Prostacyclin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here